Hottest developments in the field of cardiology in 2020. Section 3: Heart failure dr. Abhimanyu Uppal25 Dec 2020 9:15 PM ISTInteresting developments have shown promise to improve the management of heart failure in 2020. From introducing the arrival of myosin inhibitors in...
2020 in a nutshell: The hottest developments in field of cardiology this year. Section 2. Atrial fibrillation dr. Abhimanyu Uppal25 Dec 2020 8:45 AM ISTExciting researches continue to swirl around the niche of atrial fibrillation and its management. The year 2020 marked the advent of cryoablation as a...
2020 in a nutshell: The hottest developments in the field of cardiology this year. Section 1. General and preventive cardiology dr. Abhimanyu Uppal24 Dec 2020 12:45 PM ISTFrom addressing the concerns of ACE inhibitors in the COVID19 era to defining a new target population for antihypertensive treatment, the following...
Impact of Azelnidipine in reducing urinary albumin excretion and carotid atherosclerosis in type 2 diabetes patients: BOAT 2 study Review Prem Aggarwal15 Dec 2020 12:45 PM ISTHypertension and Diabetes Mellitus are the global health burden and strong risk factors for coronary artery disease (1). Impaired glucose tolerance...
Use of Probiotics in the Management of Hypertension - Exploring the Potential Hina Zahid10 Dec 2020 12:45 PM ISTHypertension has become a common chronic medical condition affecting > 20% of adult population worldwide. It is certainly established to be a...
Azelnidipine versus Amlodipine in hypertensive diabetics with albuminuria: Review Prem Aggarwal27 Nov 2020 12:45 PM ISTHypertension is common among diabetics and those who have chronic kidney disease. Both hypertension and diabetes are associated with increased...
Hypertension in Diabetes: Considering Therapies which Optimise Kidney Protection Dr Sujoy Ghosh20 Nov 2020 11:25 AM ISTHypertension and Diabetes remain the top two causes of End-Stage Renal Disease (ESRD) (1). Hence, it seems clinically appropriate to establish that...
Hypertension and Kidney: Choosing the Right Therapeutic Agent for BP Control and Nephroprotection Dr. Arun Shah11 Nov 2020 11:30 AM ISTIn the management of hypertension, the treatment goals need to be dual with equal emphasis – i.e. to reduce the blood pressure levels and provide...
Role of Azelnidipine on management of BP in hypertensive Diabetics: Review Prem Aggarwal4 Nov 2020 11:09 AM ISTHypertensive patients with type 2 diabetes carry a high cardiovascular risk. Most patients with hypertension and diabetes face higher mortality due to...
Vitamin K dependent Matrix Gla Protein as a Marker for Vascular Calcification in Chronic Kidney Disease: Study Dr Kartikeya Kohli2 Nov 2020 11:55 AM ISTOne of the major causes of mortality in CKD patients is cardiovascular complications. Vascular calcification, regarded to be a common cause of...
BPLTTC: Using Antihypertensive agents as risk modifiers for prevention of CV events irrespective of baseline criteria: Scope of Amlodipine Prem Aggarwal13 Oct 2020 12:17 PM ISTHypertension, a prominent cause of premature mortality, affects ~1.13 billion people worldwide, though blood pressure (BP) control rates remain dismal...
Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension? Prem Aggarwal10 Oct 2020 10:30 AM ISTHypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...
